A Study of CT0596 in Plasma Cell Leukemia

Clinical trial NCT06988059 · RECRUITING

Trial details

NCT number: NCT06988059
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Plasma Cell Leukemia

Start date: 2025-06-25
Primary completion: 2027-01-03
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.